SCHEMBL4193390

SCHEMBL4193390

CCc1cc2ccc1o2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29924271 0.82 HSD17B3 (0.38)
SCHEMBL8470589 0.82 HSD17B3 (0.38)
SCHEMBL5489008 0.77 TYR (0.41)
SCHEMBL22458615 0.76 GABRA1 (0.38)
SCHEMBL21705667 0.76 HSD17B3 (0.40)
SCHEMBL7177601 0.76 TYR (0.43)
SCHEMBL29923984 0.76 HCAR2 (0.37)
SCHEMBL11274887 0.74 AKR1B1 (0.42)
SCHEMBL18867816 0.73 KDM4E (0.48)
SCHEMBL29557236 0.73 HTR2C (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032628-A2 POLY(ARYLENE ETHER) BLOCK COPOLYMER COMPOSITIONS, METHODS, AND ARTICLES Sabic Innovative Plastics IP B.V. (NL) 2009-03-11 EP claimed
WO-2007106296-A2 POLY(ARYLENE ETHER) BLOCK COPOLYMER COMPOSITIONS, METHODS, AND ARTICLES SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2007-09-20 WO claimed
US-20200216467-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE IDORSIA PHARMACEUTICALS LTD (CH) 2020-07-09 US disclosed
US-9956222-B2 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof Xuanzhu Pharma Co., Ltd. (CN) 2018-05-01 US disclosed
US-20170136023-A1 QUINAZOLINE DERIVATIVE AS TYROSINE-KINASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Xuanzhu Pharma Co., Ltd. (CN) 2017-05-18 US disclosed
US-9586939-B2 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof Xuanzhu Pharma Co., Ltd. (CN) 2017-03-07 US disclosed
EP-1761382-A1 MULTILAYER COMPOSITES WITH SPECIAL VISUAL EFFECTS GENERAL ELECTRIC COMPANY (US) 2007-03-14 EP disclosed
WO-2006007419-A1 MULTILAYER COMPOSITES WITH SPECIAL VISUAL EFFECTS GENERAL ELECTRIC COMPANY (US) 2006-01-19 WO disclosed
EP-0583484-B1 STYRENIC RESIN COMPOSITION IDEMITSU KOSAN CO (JP) 2000-02-02 EP disclosed
US-5391611-A High strength, impact strength,heat resistance, fireproof IDEMITSU KOSAN CO., LTD. (JP) 1995-02-21 US disclosed
EP-0583484-A1 STYRENIC RESIN COMPOSITION IDEMITSU KOSAN COMPANY LIMITED (JP) 1994-02-23 EP disclosed
US-4373065-A Optically isotropic devices XEROX CORPORATION (US) 1983-02-08 US disclosed